Only in metastatic prostate cancer patients, a preliminary data that increased expression of KiSS-1 is able to sensitize cancer cells to chemotherapies (22, 23); in the same setting of patients, expression of KiSS-1 is inversely correlated with tumor differentiation and clinical staging. Here, KISS1 is linked to neoplasm.